Inflammatory arthritis
Conditions
Interventions
For this study, the Pico G2 4K VR headset will be used in combination with the
VR training app Reducept. The Pico G2 is an all-in-one VR headset with an
ergonomic design and a simple remote control
Sponsors
Medisch Spectrum Twente (MST)
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Diagnosis of rheumatoid arthritis, psoriatic arthritis or spondyloarthritis - Disease duration >= 2 years - Chronic pain symptoms (NRS pain >= 4 at >= 2 moments with >= 6 months between or NRS pain >= 4 at one moment + treating rheumatologist*s opinion about chronic pain) despite low disease activity (DAS28/DAPSA/ASDAS low disease activity at 2 moments >= 6 months between or DAS28/DAPSA/ASDAS low disease activity at one moment + treating rheumatologist*s opinion about low disease activity in the past 6 months) - Home access to WIFI
Exclusion criteria
Exclusion criteria: - Active disease - Severe audio-visual impairments - Any of the following comorbidities: dizziness, limited cognition, balance disorders, claustrophobia, fear of heights (if it makes the use of the VR headset impossible) -Diagnosed with psychotic disorders, dementia or other disorders that preclude adherence to study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity (NRS score) - In the VR group this is measured immediately before and immediately after using Reducept, and always twice a day. - In the control group this is measured once a week. | — |
Secondary
| Measure | Time frame |
|---|---|
| Before the start of the study, the following parameters are measured: - Baseline variables (e.g. age, gender, occupation, comorbidities, etc.) - Treatment Expectancy (ETS) - VR disease (VRSQ) - Qualitative Pain Assessment (GPQ) During the study, the following parameters are measured in the intervention group: - Type of painkillers, dosage and frequency since last requested: measured daily between 3:00 PM and 8:00 PM - Fatigue (NRS score): measured twice a day - Number of steps per day, measured during the entire study via the integrated pedometer in the SEMA3 app During the study, the following parameters are measured in the control group: - Type of painkillers, dosage and frequency for 1 week - Fatigue (NRS score): once a week. The following parameters are measured before the start and after the end of the study: - Pain catastrophizing (PCS) - Disease activity (DAS28, DAPSA, ASDAS) - Quality of life (SF-36) - Physical functioning (HAQ-DI) - Self-efficacy (ASES) After completion of the study, the following parameters are measured: - Evaluation of VR | — |
Countries
Netherlands
Contacts
Public ContactM.C. Hegeman
Medisch Spectrum Twente (MST)
Outcome results
None listed